There are several compelling reasons to invest in pharmaceutical companies, especially when the economy isn't doing well.

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by ...

Daito Pharmaceutical Co., Ltd. ( ($JP:4577) ) has issued an update. Daito Pharmaceutical Co., Ltd. reported a 2.6% increase in net sales for the ...

Rubicon Research’s ₹ IPO issue was subscribed 84% on the second day, with strong demand from retail investors. The company’s ...

India's Natco Pharma is set to acquire significant stakes in South Africa's Adcock Ingram, which will become a privately-held ...

Eli Lilly's weight-loss drug Mounjaro is rapidly climbing the ranks in the Indian pharmaceutical market, nearing ...

A Milan judge has seized 2.3 million euros ($2.7 million) from pharmaceutical multinational Novartis as part of a fraud investigation, a document seen by Reuters shows.

Rubicon Research is a pharmaceutical formulation company with a strong focus on R&D and innovation. Its portfolio includes an ...

Rubicon Research IPO price band is set at ₹461 to ₹485 per share. Rubicon Research IPO GMP remains strong at more than 20% on ...

The buyout could be worth as much as $5.2 billion.

Singapore's industrial output blew past forecasts to rise 24.2% year-on-year in September, its fastest pace in nine years, boosted by pharmaceutical manufacturing more than doubling last month, ...

Pharmaceutical giant Johnson & Johnson (J&J) has been ordered to pay AU$1.47 billion (US$966 million) to the family of a US ...